Suchergebnisse - "antibodies"

PubPharm (1.549)

1

Use of LDBIO Diagnostics® TOXOPLASMA ICT IGG-IGM in association with Siemens Atellica® IM in toxoplasmosis serological screening

enthalten in: Annales de biologie clinique | 2024

von Fortun, M. | L'hirondel, J.

2

Epcoritamab - relapsed or refractory large diffuse B cells lymphoma after two or more lines of systemic therapy

enthalten in: Bulletin du cancer | 2024

von Bensaber, H. | Cacheux, V.

3

Understanding hypersensitivity reactions to monoclonal antibodies

enthalten in: Revue medicale suisse | 2024

von Cattaneo, V. | Belkoniene, M. | Porret, R. | +2

4

Bronchial involvement in granulomatosis with polyangiitis

enthalten in: Revue des maladies respiratoires | 2024

von Batton, R. | Le Guen, P. | Cazes, A. | +2

5

Sacituzumab-govitecan in hormone-receptor positive/HER2-negative advanced breast cancer

enthalten in: Bulletin du cancer | 2024

von Besnainou, H. | Cabel, L.

6

High anti-topoisomerase-1 autoantibodies levels are associated with the extension of skin fibrosis and vascular progression in patients with systemic sclerosis

enthalten in: La Revue de medecine interne | 2024

von Dol, C. | Granel, B. | Resseguier, N. | +9

7

Pembrolizumab in adjuvant therapy in non-small cell lung cancers

enthalten in: Bulletin du cancer | 2024

von Lefèvre, A. | Tissot, C.

8

Talquetamab - multiple myeloma after at least three prior lines of therapy

enthalten in: Bulletin du cancer | 2024

von Fatrara, T. | Chalayer, E.

9

Characteristics and prognosis of acute renal failure on dialysis in ANCA vasculitis

enthalten in: Nephrologie & therapeutique | 2024

von Siham, A. | Hafedh, F. | Jean-Jacques, B. | +1

10

Pembrolizumab with trastuzumab and chemotherapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinomas with surexpression of HER2 and CPS≥1

enthalten in: Bulletin du cancer | 2024

von Lévêque, I. | Spitzer, E.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[155]